Takotsubo syndrome due to 4-fluoroamphetamine

Clinical Toxicology

Volumn 53, Issue 2, 2015, Pages 136-

  Madias, John E ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 FLUOROAMPHETAMINE; AMPHETAMINE; ILLICIT DRUG; UNCLASSIFIED DRUG; AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; STREET DRUG;

ADULT; CARDIOGENIC SHOCK; CASE REPORT; ELECTROCARDIOGRAM; HUMAN; LETTER; MALE; ST SEGMENT ELEVATION; TAKOTSUBO CARDIOMYOPATHY; TOPOGRAPHY; CHEMICALLY INDUCED; COMPLICATION; DRUG ABUSE;

AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MALE; SHOCK, CARDIOGENIC; STREET DRUGS;

EID: 84922961257     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.998767     Document Type: Letter

References (2)

1. Al-Abri SA, Meier KH, Colby JM, Smollin CG, Benowitz NL. Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels. Clin Toxicol (Phila) 2014; 28: 1-4. [Epub ahead of print].
2. http://www.ncbi.nlm.nih.gov/pubmed/?term=takotsubo (last accessed on 11/21/14).